Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment

Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment

IntroductionTriple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer resistant to endocrine and targeted therapies. Immune checkpoint inhibitors (ICIs) have shown significant efficacy in various cancers. Taraxacum officinale, commonly known as dandelion, has traditionally been...

Full description

Bibliographic Details
Main Authors: Tangyi Wang, Yadian Lei, Jingwei Sun, Li Wang, Yuxin Lin, Zhijing Wu, Shoude Zhang, Chengzhu Cao, Haiyan Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
immune checkpoint blockade
triple-negative breast cancer
malignant phenotype
nanos1
PD-1 inhibitors
tumor microenvironments
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1536406/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1536406/full

Similar Items